Drug firm blames price cuts for unit sale

The drug distribution group UDG has blamed significant drug price cuts demanded by the HSE and the North’s National Health Service as one of its reasons for selling off its wholesale division for more than €400 million last week.

Speaking to The Sunday Business Post, the UDG chief executive Liam Fitzgerald said price cuts have averaged 4 to 5 per cent per year even though the company was delivering the same, if not ...